Govt Job for Pharmacists in Government Ophthalmic Hospital

Applications are invited from eligible candidates for the following posts on contract basis only for six months on contract basis for C-19 Disaster and Corona Disease Prevention and Ophthalmology Center and Government Eye Hospital, Egmore, Chennai – 8.

Post : Pharmacist

No of Posts : 05

Qualification : D.Pharm, B.Pharm

Salary : Rs 12,000/- per month

Furthermore, it is informed that these posts will not be filled permanently and for whatever reason.

Eligible and interested applicants are advised to send their photocopies of applications along with photocopies of all their educational qualifications to this website either directly or by post.

Address to which application should be sent
Director Prof. Zonal Ophthalmology Center and Government Eye Hospital, Egmore, Chennai – 600008

Last day to apply : 24.09.2021 Applications received after the due date (24.09.2021) will not be accepted.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices